The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJordan Collaborating Cardiology Group

About this trial

Cardiovascular-renal-metabolic (CRM) syndrome is defined as a systemic disorder with a collection of related signs and symptoms attributable to the coexistence of multiple cardiovascular, renal and metabolic disease with a common underlying pathophysiology in one individual. Surveying this syndrome in a large population in Jordan aims at studying the risk factors, components and stages of the syndrome, thus helping early screening, diagnosing and treating disease and its risk factors.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults (age 18 years and above).

Willing to sign an informed consent.

Disqualifiers

None.

Trial population

Consecutive individuals (N=10,000) visiting allocated medical laboratories in North, Center, and South sections of the country during public free blood testing campaigns planned in August 2024 to June 2025.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Prevalence of cardiovascular-renal-metabolic syndrome

1. CVD A. Coronary heart disease: Silent and clinical CAD (chronic stable coronary disease, acute coronary disease \[ST-elevation myocardial infarction and non-ST-elevation acute coronary syndrome\]. B. Heart failure. C. Atrial fibrillation. D. Stroke. E. Peripheral artery disease 2. Renal: chronic kidney disease 3. Metabolic: A. Obesity/ B. Diabetes mellitus (DM).

Time frame
From date of study entry through study completion, an average of 1 year

Secondary outcomes

1

Elevated levels of blood markers

Elevated level of lipoprotein (a) , homocysteine, high sensitivity C-Reactive Protein, insulin resistance, and Urine Creatinine/Albumin ratio.

Time frame
From date of study entry through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jordan Collaborating Cardiology Group

Lead sponsor

Cardiovascular Academy

Collaborator

The Association of Jordanian Medical Laboratory Specialists AJMLS

Collaborator

This trial is not recruiting at the moment. You can still explore other options: